Q1 EPS Estimates for Cinemark Reduced by Barrington Research

Cinemark Holdings, Inc. (NYSE:CNK - Free Report) - Equities researchers at Barrington Research lowered their Q1 2025 earnings estimates for shares of Cinemark in a report issued on Monday, March 24th. Barrington Research analyst P. Sholl now forecasts that the company will earn ($0.26) per share for the quarter, down from their prior forecast of ($0.07). Barrington Research has a "Outperform" rating and a $40.00 price objective on the stock. The consensus estimate for Cinemark's current full-year earnings is $1.93 per share. Barrington Research also issued estimates for Cinemark's Q2 2025 earnings at $0.50 EPS, Q3 2025 earnings at $0.57 EPS, Q4 2025 earnings at $0.44 EPS, Q1 2026 earnings at ($0.07) EPS, Q2 2026 earnings at $0.68 EPS, Q3 2026 earnings at $0.77 EPS and Q4 2026 earnings at $0.52 EPS.

Cinemark (NYSE:CNK - Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The company reported $0.33 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.39 by ($0.06). Cinemark had a return on equity of 65.83% and a net margin of 10.16%. The business had revenue of $814.30 million for the quarter, compared to analysts' expectations of $797.18 million. During the same period last year, the firm earned ($0.15) earnings per share. The firm's quarterly revenue was up 27.5% on a year-over-year basis.

Several other brokerages have also issued reports on CNK. Wedbush reaffirmed a "neutral" rating and set a $32.00 price objective on shares of Cinemark in a report on Tuesday, February 18th. Macquarie reaffirmed an "outperform" rating and set a $35.00 price target on shares of Cinemark in a research report on Thursday, February 20th. Wells Fargo & Company lowered their target price on shares of Cinemark from $38.00 to $36.00 and set an "overweight" rating on the stock in a research report on Wednesday, January 29th. JPMorgan Chase & Co. decreased their price target on shares of Cinemark from $31.00 to $30.00 and set a "neutral" rating for the company in a research note on Thursday, February 20th. Finally, Morgan Stanley dropped their price objective on shares of Cinemark from $40.00 to $35.00 and set an "overweight" rating on the stock in a research note on Thursday, February 20th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, six have given a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat, Cinemark currently has an average rating of "Moderate Buy" and an average target price of $32.70.

Remove Ads

Cinemark Stock Down 1.8 %

CNK traded down $0.45 on Thursday, reaching $24.39. The company's stock had a trading volume of 434,767 shares, compared to its average volume of 2,901,263. The company has a quick ratio of 0.96, a current ratio of 1.01 and a debt-to-equity ratio of 3.28. Cinemark has a fifty-two week low of $16.32 and a fifty-two week high of $36.28. The stock has a 50 day moving average of $27.54 and a two-hundred day moving average of $29.41. The company has a market capitalization of $2.98 billion, a price-to-earnings ratio of 12.00 and a beta of 2.41.

Institutional Investors Weigh In On Cinemark

A number of institutional investors have recently modified their holdings of the stock. Mackenzie Financial Corp bought a new stake in Cinemark in the fourth quarter valued at about $221,000. Elequin Capital LP grew its position in shares of Cinemark by 211.6% in the 4th quarter. Elequin Capital LP now owns 997 shares of the company's stock worth $31,000 after acquiring an additional 677 shares in the last quarter. PharVision Advisers LLC bought a new stake in shares of Cinemark in the 4th quarter valued at approximately $277,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in shares of Cinemark by 24.0% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 319,768 shares of the company's stock valued at $9,906,000 after acquiring an additional 61,911 shares in the last quarter. Finally, Voloridge Investment Management LLC bought a new position in Cinemark during the fourth quarter worth $8,317,000.

Insiders Place Their Bets

In other Cinemark news, insider Wanda Marie Gierhart sold 9,119 shares of the firm's stock in a transaction on Tuesday, February 25th. The shares were sold at an average price of $27.00, for a total transaction of $246,213.00. Following the completion of the transaction, the insider now directly owns 147,414 shares of the company's stock, valued at $3,980,178. This trade represents a 5.83 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 2.30% of the stock is owned by company insiders.

Cinemark Dividend Announcement

The firm also recently disclosed a -- dividend, which was paid on Wednesday, March 19th. Shareholders of record on Wednesday, March 5th were paid a dividend of $0.08 per share. The ex-dividend date was Wednesday, March 5th. Cinemark's dividend payout ratio (DPR) is presently 15.76%.

Cinemark Company Profile

Cinemark Holdings, Inc, together with its subsidiaries, engages in the motion picture exhibition business. As of February 16, 2024, it operated 501 theatres with 5,719 screens in 42 states and 13 countries in South and Central America. Cinemark Holdings, Inc was founded in 1984 and is headquartered in Plano, Texas.